617 filings
Page 12 of 31
8-K
gvm8jb9z g81ol
8 Aug 19
Regulation FD Disclosure
1:30pm
8-K
oeu3ynwh dfi0gf
5 Aug 19
VBI Vaccines to Present at the Canaccord Genuity 39th Annual Growth Conference
11:04am
8-K
uulsica57in rjcv
29 Jul 19
VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Part B of Ongoing Phase 1/2a Study of VBI-1901
9:32am
8-K
7eeug8l6hkh6
21 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
cehwn7
17 Jun 19
Regulation FD Disclosure
7:59am
8-K
7wunax0a vme5fw
14 Jun 19
VBI Vaccines Announces Results of Annual General Meeting
6:05am
8-K
lgu5dwon axj
4 Jun 19
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019
2:25pm
DEFA14A
rzrt2iut20
10 May 19
Additional proxy soliciting materials
4:05pm
8-K
ganlqndrb56xnl
1 May 19
VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update
12:33pm
DEFA14A
3moi4h19eke7t 5qc
29 Apr 19
Additional proxy soliciting materials
4:15pm
8-K
yk8872 he4kr0xtrw16
26 Apr 19
Departure of Directors or Certain Officers
4:05pm
8-K
5o4gy03
25 Apr 19
Regulation FD Disclosure
8:00am
8-K
efb8f2hon
24 Apr 19
VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call
2:25pm
8-K
7lim6h9vf q5cqj
17 Apr 19
VBI Vaccines Appoints Dr. Vlad Popovic as Vice President of Clinical Development and Medical Affairs
12:13pm
8-K
6umpz81fxzx
12 Apr 19
VBI Vaccines Appoints Joanne Cordeiro to Board of Directors
1:44pm
8-K
nwoxkbyq6bhkp8h xr2a
9 Apr 19
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
3:16pm
8-K
e9bj oysw8s0
3 Apr 19
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV
4:30pm